ELISA methods to measure cholinergic markers and nerve growth factor receptors in cortex, hippocampus, prefrontal cortex, and basal forebrain from rat brain

被引:37
作者
Gearhart, DA [1 ]
Middlemore, ML [1 ]
Terry, AV [1 ]
机构
[1] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Dept Clin & Adm Pharm, Augusta, GA 30912 USA
关键词
acetylcholine; choline; NGF; cognition; high-throughput; Alzheimer's disease; schizophrenia;
D O I
10.1016/j.jneumeth.2005.06.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The central cholinergic system has a fundamental role in normal cognitive function, and in diseases that exhibit cognitive dysfunction. The purpose of this study was to design ELISA methods to measure proteins that have essential functions in the central cholinergic system. We were particularly interested in quantifying proteins that respond directly or indirectly to nerve growth factor (NGF). ELISAs offer advantages over Western blot analyses and other methods, such as increased sensitivity, decreased assay variability, increased efficiency, and decreased cost. We developed indirect ELISA methods for: choline acetyltransferase (ChAT); the vesicular acetylcholine transporter (VAChT); the high affinity choline transporter (HACT/CHT); TrkA, the high affinity NGF receptor; the p75 neurotrophin receptor (p75(NTR)). A sandwich ELISA was developed to measure tyrosine-phosphorylated TrkA in brain lysates. We used these ELISAs to compare levels of the above proteins in important memory-related brain regions - basal forebrain, hippocampus, cortex, and prefrontal cortex - from old and young rats. We identified age-related differences in the levels of the aforementioned proteins (e.g., VAChT and HACT/CHT in hippocampus). Thus, these ELISA methods should be particularly useful for comparing the effects of age, disease, drugs, and toxicants on brain levels of key cholinergic and growth factor-related proteins. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:159 / 173
页数:15
相关论文
共 56 条
[41]   Establishment of an efficient enzyme-linked immunosorbent assay for the determination of human choline acetyltransferase [J].
Poethke, R ;
Tumani, H ;
Felgenhauer, K ;
Mader, M .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 76 (1-2) :206-212
[42]   Characterization of monoclonal and polyclonal antibodies to human choline acetyltransferase and epitope analysis [J].
Poethke, R ;
Hartig, W ;
Bruckner, G ;
Felgenhauer, K ;
Mader, M .
BIOLOGICAL CHEMISTRY, 1997, 378 (09) :997-1004
[43]   ENZYME-IMMUNOASSAY TECHNIQUES - AN OVERVIEW [J].
PORSTMANN, T ;
KIESSIG, ST .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 150 (1-2) :5-21
[44]   Chlorpyrifos exposure during neurulation: cholinergic synaptic dysfunction and cellular alterations in brain regions at adolescence and adulthood [J].
Qiao, D ;
Seidler, FJ ;
Abreu-Villaca, Y ;
Tate, CA ;
Cousins, MM ;
Slotkin, TA .
DEVELOPMENTAL BRAIN RESEARCH, 2004, 148 (01) :43-52
[45]   Kinesin-II is required for axonal transport of choline acetyltransferase in Drosophila [J].
Ray, K ;
Perez, SE ;
Yang, ZH ;
Xu, J ;
Ritchings, BW ;
Steller, H ;
Goldstein, LSB .
JOURNAL OF CELL BIOLOGY, 1999, 147 (03) :507-517
[46]  
ROSKAMS J, 2002, LAB REF HDB RECIPES, P272
[47]  
Ruberti F, 2000, J NEUROSCI, V20, P2589
[48]   Alzheimer's disease and NGF signaling [J].
Salehi, A ;
Delcroix, JD ;
Swaab, DF .
JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (03) :323-345
[49]   Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates [J].
Slotkin, TA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 198 (02) :132-151
[50]   The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development [J].
Terry, AV ;
Buccafusco, JJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03) :821-827